Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
23.04
-1.48 (-6.04%)
At close: Jul 10, 2026, 4:00 PM EDT
23.04
0.00 (0.00%)
After-hours: Jul 10, 2026, 4:10 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.95 billion as of July 10, 2026. Its market cap has increased by 563.39% in one year.
Market Cap
1.95B
Enterprise Value
1.33B
1-Year Change
563.39%
Ranking
Category
Stock Price
$23.04
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.95B, an increase of 130.26%. That is a compound annual growth rate of 17.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.95B | 90.63% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 2.13B |
| ADMA Biologics | 2.11B |
| Kardigan | 2.09B |
| Taysha Gene Therapies | 2.06B |
| Stoke Therapeutics | 2.04B |
| Sionna Therapeutics | 2.03B |
| Lakefront Biotherapeutics NV | 2.01B |
| Recursion Pharmaceuticals | 2.00B |